{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:42:44Z","timestamp":1792078964877,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK007634"],"award-info":[{"award-number":["DK007634"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10620-019-05756-7","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T05:15:50Z","timestamp":1564463750000},"page":"322-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis"],"prefix":"10.1007","volume":"65","author":[{"given":"Karan","family":"Mathur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahin","family":"Vuppalanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Gelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Vuppalanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3809-640X","authenticated-orcid":false,"given":"Craig","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"5756_CR1","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","volume":"382","author":"MA Heneghan","year":"2013","unstructured":"Heneghan MA, Yeoman AD, Verma S, et al. Autoimmune hepatitis. Lancet. 2013;382:1433\u20131444.","journal-title":"Lancet"},{"key":"5756_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"EASL Clinical Practice Guidelines","year":"2015","unstructured":"EASL Clinical Practice Guidelines. Autoimmune hepatitis. J Hepatol. 2015;63:971\u20131004.","journal-title":"J Hepatol"},{"key":"5756_CR3","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193\u20132213.","journal-title":"Hepatology"},{"key":"5756_CR4","doi-asserted-by":"publisher","first-page":"e0204772","DOI":"10.1371\/journal.pone.0204772","volume":"13","author":"A Takahashi","year":"2018","unstructured":"Takahashi A, Moriya K, Ohira H, et al. Health-related quality of life in patients with autoimmune hepatitis: a questionnaire survey. PLoS ONE. 2018;13:e0204772.","journal-title":"PLoS ONE"},{"key":"5756_CR5","unstructured":"Vuppalanchi V, Chalasani S, Mohammad S, et al. Patient reported outcomes of physical and psychological suffering in patients with autoimmune hepatitis. In: American College of Gastroenterology. October 5\u201310, 2019, Philadelphia. Abstract #P2376."},{"key":"5756_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/liv.13960","volume":"39","author":"MK Janik","year":"2019","unstructured":"Janik MK, Wunsch E, Raszeja-Wyszomirska J, et al. Autoimmune hepatitis exerts a profound, negative effect on health-related quality of life: a prospective, single-centre study. Liver Int. 2019;39:215\u2013221.","journal-title":"Liver Int"},{"key":"5756_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11136-006-9131-y","volume":"16","author":"SM van der Plas","year":"2007","unstructured":"van der Plas SM, Hansen BE, de Boer JB, et al. Generic and disease-specific health related quality of life of liver patients with various aetiologies: a survey. Qual Life Res. 2007;16:375\u2013388.","journal-title":"Qual Life Res"},{"key":"5756_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ecam\/nen023","volume":"7","author":"FL Bishop","year":"2010","unstructured":"Bishop FL, Lewith GT. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Altern Med eCAM. 2010;7:11\u201328.","journal-title":"Evid Based Complement Altern Med eCAM"},{"key":"5756_CR9","first-page":"1","volume":"2004","author":"PM Barnes","year":"2002","unstructured":"Barnes PM, Powell-Griner E, McFann K, et al. Complementary and alternative medicine use among adults: United States. Adv Data. 2002;2004:1\u201319.","journal-title":"Adv Data"},{"key":"5756_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.yebeh.2016.11.012","volume":"70","author":"BK O\u2019Connell","year":"2017","unstructured":"O\u2019Connell BK, Gloss D, Devinsky O. Cannabinoids in treatment-resistant epilepsy: a review. Epilepsy Behav. 2017;70:341\u2013348.","journal-title":"Epilepsy Behav"},{"key":"5756_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/17474124.2017.1292851","volume":"11","author":"C Hasenoehrl","year":"2017","unstructured":"Hasenoehrl C, Storr M, Schicho R. Cannabinoids for treating inflammatory bowel diseases: Where are we and where do we go? Expert Rev Gastroenterol Hepatol. 2017;11:329\u2013337.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"5756_CR12","first-page":"Cd012853","volume":"11","author":"TS Kafil","year":"2018","unstructured":"Kafil TS, Nguyen TM, MacDonald JK, et al. Cannabis for the treatment of Crohn\u2019s disease. Cochrane Database Syst Rev. 2018;11:Cd012853.","journal-title":"Cochrane Database Syst Rev"},{"key":"5756_CR13","doi-asserted-by":"publisher","first-page":"e1345","DOI":"10.1542\/peds.2013-2966","volume":"133","author":"KR Schumacher","year":"2014","unstructured":"Schumacher KR, Stringer KA, Donohue JE, et al. Social media methods for studying rare diseases. Pediatrics. 2014;133:e1345\u2013e1353.","journal-title":"Pediatrics"},{"key":"5756_CR14","doi-asserted-by":"publisher","first-page":"S526","DOI":"10.14309\/00000434-201810001-00942","volume":"113","author":"S Chalasani","year":"2018","unstructured":"Chalasani S, Vuppalanchi V, Tilmans L, et al. Novel approach leveraging social media indicates complementary and alternative medicine use highly prevalent and is sometimes associated with serious adverse events in patients with autoimmune hepatitis. American Journal of Gastroenterology. 2018;113:S526.","journal-title":"American Journal of Gastroenterology"},{"key":"5756_CR15","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.2196\/jmir.7683","volume":"20","author":"M Comerford","year":"2018","unstructured":"Comerford M, Fogel R, Bailey JR, et al. Leveraging social networking sites for an autoimmune hepatitis genetic repository: pilot study to evaluate feasibility. J Med Internet Res. 2018;20:e14.","journal-title":"J Med Internet Res"},{"key":"5756_CR16","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.2196\/ijmr.9625","volume":"7","author":"R Fogel","year":"2018","unstructured":"Fogel R, Comerford M, Chilukuri P, et al. Extrahepatic autoimmune diseases are prevalent in autoimmune hepatitis patients and their first-degree relatives: survey study. Interact J Med Res. 2018;7:e18.","journal-title":"Interact J Med Res"},{"key":"5756_CR17","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1136\/gut.2008.148791","volume":"57","author":"AA Izzo","year":"2008","unstructured":"Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut. 2008;57:1140\u20131155.","journal-title":"Gut"},{"key":"5756_CR18","first-page":"455","volume":"13","author":"T Naftali","year":"2011","unstructured":"Naftali T, Lev LB, Yablecovitch D, et al. Treatment of Crohn\u2019s disease with cannabis: an observational study. Isr Med Assoc J. 2011;13:455\u2013458.","journal-title":"Isr Med Assoc J"},{"issue":"1276\u20131280","key":"5756_CR19","first-page":"e1","volume":"11","author":"T Naftali","year":"2013","unstructured":"Naftali T, Bar-Lev Schleider L, Dotan I, et al. Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study. Clin Gastroenterol Hepatol. 2013;11(1276\u20131280):e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5756_CR20","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"313","author":"PF Whiting","year":"2015","unstructured":"Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313:2456\u20132473.","journal-title":"JAMA"},{"key":"5756_CR21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/MEG.0000000000001256","volume":"30","author":"H Goyal","year":"2018","unstructured":"Goyal H, Rahman MR, Perisetti A, et al. Cannabis in liver disorders: a friend or a foe? Eur J Gastroenterol Hepatol. 2018;30:1283\u20131290.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"5756_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/14740338.2017.1397128","volume":"17","author":"C Rong","year":"2018","unstructured":"Rong C, Carmona NE, Lee YL, et al. Drug-drug interactions as a result of co-administering delta(9)-THC and CBD with other psychotropic agents. Expert Opin Drug Saf. 2018;17:51\u201354.","journal-title":"Expert Opin Drug Saf"},{"key":"5756_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fphar.2016.00279","volume":"7","author":"MR Peace","year":"2016","unstructured":"Peace MR, Butler KE, Wolf CE, et al. Evaluation of two commercially available cannabidiol formulations for use in electronic cigarettes. Front Pharmacol. 2016;7:279.","journal-title":"Front Pharmacol"},{"key":"5756_CR24","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2017.11909","volume":"318","author":"MO Bonn-Miller","year":"2017","unstructured":"Bonn-Miller MO, Loflin MJE, Thomas BF, et al. Labeling accuracy of cannabidiol extracts sold online. JAMA. 2017;318:1708\u20131709.","journal-title":"JAMA"},{"key":"5756_CR25","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"MA Huestis","year":"2007","unstructured":"Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007;4:1770\u20131804.","journal-title":"Chem Biodivers"},{"key":"5756_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/MCG.0000000000000617","volume":"51","author":"JB Henson","year":"2017","unstructured":"Henson JB, Brown CL, Chow SC, et al. Complementary and alternative medicine use in United States adults with liver disease. J Clin Gastroenterol. 2017;51:564\u2013570.","journal-title":"J Clin Gastroenterol"},{"key":"5756_CR27","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/hep.30031","volume":"68","author":"LL Wong","year":"2018","unstructured":"Wong LL, Fisher HF, Stocken DD, et al. The impact of autoimmune hepatitis and its treatment on health utility. Hepatology. 2018;68:1487\u20131497.","journal-title":"Hepatology"},{"key":"5756_CR28","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jhep.2013.10.035","volume":"60","author":"C Schramm","year":"2014","unstructured":"Schramm C, Wahl I, Weiler-Normann C, et al. Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis. J Hepatol. 2014;60:618\u2013624.","journal-title":"J Hepatol"},{"key":"5756_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.cgh.2017.02.015","volume":"15","author":"A Kulanthaivel","year":"2017","unstructured":"Kulanthaivel A, Fogel R, Jones J, et al. Digital cohorts within the social mediome: an approach to circumvent conventional research challenges? Clin Gastroenterol Hepatol. 2017;15:614\u2013618.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5756_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15398","author":"AD Leino","year":"2019","unstructured":"Leino AD, Emoto C, Fukuda T, Privitera M, Vinks AA, Alloway RR. Evidence of a clinically significant drug\u2013drug interaction between cannabidiol and tacrolimus. Am J Transplant. 2019. \nhttps:\/\/doi.org\/10.1111\/ajt.15398\n\n.","journal-title":"Am J Transplant"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05756-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05756-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05756-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T23:32:32Z","timestamp":1595979152000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05756-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5756"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05756-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]},"assertion":[{"value":"24 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}